By joining forces and combining technologies in a new way, Harvard Medical School researchers have captured the first bird’s eye views of what happens at the molecular level when drugs, hormones and neurotransmitters activate certain kinds of cell receptors. Until now, scientists had been able to see only one part of the picture at a time.
The novel coronavirus sweeping the globe packs 27 proteins, each adopting a unique, often incredibly complex 3D structure. Each protein is part of the molecular toolkit that the virus uses to infect, replicate, and spread. Understanding the proteins' structures provides a blueprint for drug designs.WATCH NOW
Dr. Fabiana Quaglia, Associate Professor of Pharmaceutical Technology at the Faculty of Pharmacy–University of Napoli Federico II, Italy discusses how reliability and smart features of the rotary evaporator, Rotavapor® R-300, let her easily evaporate solvents in particle production for cancer and cystic fibrosis drug development and formulation.WATCH NOW